-+ 0.00%
-+ 0.00%
-+ 0.00%

Karyopharm Therapeutics shareholders approve 3 million-share increase to 2022 equity plan at annual meeting

PUBT·05/28/2026 20:25:29
Listen to the news
Karyopharm Therapeutics shareholders approve 3 million-share increase to 2022 equity plan at annual meeting
  • Karyopharm held its annual stockholder meeting on May 21, 2026.
  • Stockholders backed an amendment to the 2022 Equity Incentive Plan, lifting the share reserve by 3 million shares for future issuance.
  • Stockholders also endorsed an amendment to the employee stock purchase plan, increasing the share pool by 1.4 million shares.
  • Ernst & Young was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001503802-26-000027), on May 28, 2026, and is solely responsible for the information contained therein.